S

Sebastian Stintzing

Humboldt-Universität zu Berlin

ORCID: 0000-0002-3297-5801

Publishes on Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes. 798 papers and 11.7k citations.

PubIndex Score97Top 3%How it's scored

798Publications

11.7kTotal Citations

First publication: 1997First senior author: 2009

Colorectal Cancer Treatments and Studies Lung Cancer Treatments and Mutations Gastric Cancer Management and Outcomes Genetic factors in colorectal cancer Cancer Genomics and Diagnostics

Top publicationsby citations

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial

Volker Heinemann, Sebastian Stintzing, Ludwig Fischer von Weikersthal et al.|The Lancet Oncology|2014

Cited by 1.7k

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer

Sabine Tejpar, Volker Heinemann, Sebastian Stintzing et al.|JAMA Oncology|2016

Cited by 722

The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials

Julian Walter Holch, Volker Heinemann, Ingrid Ricard et al.|European Journal of Cancer|2016

Cited by 533

FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial

Sebastian Stintzing, Volker Heinemann, Swantje Held et al.|The Lancet Oncology|2016

Cited by 417

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Dominik Paul Modest, Anke Reinacher‐Schick, Ingrid Ricard et al.|Annals of Oncology|2016

Cited by 344